Halogenated Xanthene Composition and Method for Treating Hematologic Cancers
Copyright © Targeted News Service 2024
2024-11-05
ALEXANDRIA, Virginia, Nov. 5 -- UTI LIMITED PARTNERSHIP, Calgary, Canada has been assigned a patent (No. US 12133840 B2, initially filed Aug. 18, 2022) developed by seven inventors Eric A. Wachter, Oak Ridge, Tennessee; Dominic Rodrigues, Knoxville, Tennessee; Satbir Thakur, Calgary, Canada; Lucy Swift, Calgary, Canada; Chunfen Zhang, Calgary, Canada; Mohit Jain, Calgary, Canada; and Aru Narendran, Calgary, Canada, for "Halogenated xanthene composition and method for treating hematologic cancer . . .